Literature DB >> 28127625

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.

M Kamimura1, Y Nakamura2,3, S Ikegami4, S Uchiyama4, H Kato4, A Taguchi5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28127625     DOI： 10.1007/s00198-017-3923-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  11 in total

1.  Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors:  Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2016-07-26       Impact factor: 6.741

Review 2.  Bisphosphonates and atypical femoral fractures.

Authors:  Robert A Adler
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-12       Impact factor: 3.243

3.  Ten years' experience with alendronate for osteoporosis in postmenopausal women.

Authors:  Henry G Bone; David Hosking; Jean-Pierre Devogelaer; Joseph R Tucci; Ronald D Emkey; Richard P Tonino; Jose Adolfo Rodriguez-Portales; Robert W Downs; Jayanti Gupta; Arthur C Santora; Uri A Liberman
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

Review 4.  Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Authors:  S Ishtiaq; I Fogelman; G Hampson
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

5.  Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw.

Authors:  Akira Taguchi; Masataka Shiraki; Toshitsugu Sugimoto; Hiroaki Ohta; Satoshi Soen
Journal:  Curr Med Res Opin       Date:  2016-04-19       Impact factor: 2.580

6.  Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.

Authors:  Steven R Cummings; Felicia Cosman; E Michael Lewiecki; John T Schousboe; Douglas C Bauer; Dennis M Black; Thomas D Brown; Angela M Cheung; Kathleen Cody; Cyrus Cooper; Adolfo Diez-Perez; Richard Eastell; Peyman Hadji; Takayuki Hosoi; Suzanne Jan De Beur; Risa Kagan; Douglas P Kiel; Ian R Reid; Daniel H Solomon; Susan Randall
Journal:  J Bone Miner Res       Date:  2016-12-27       Impact factor: 6.741

Review 7.  Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

Authors:  Aliya A Khan; Archie Morrison; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; David L Kendler; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

8.  Delayed wound healing after tooth extraction and self-reported kyphosis in Japanese men and women.

Authors:  Akira Taguchi; Mikio Kamimura; Yukio Nakamura; Noriyuki Sugino; Akira Ichinose; Hisayoshi Maezumi; Takashi Fukuzawa; Ryouhei Ashizawa; Kenji Takahara; Susumu Gushiken; Keijiro Mukaiyama; Shota Ikegami; Shigeharu Uchiyama; Hiroyuki Kato
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 9.  Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.

Authors:  Aliya A Khan; Archie Morrison; David L Kendler; Rene Rizzoli; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal:  J Clin Densitom       Date:  2016-12-09       Impact factor: 2.617

10.  Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.

Authors:  M Kamimura; Y Nakamura; S Ikegami; S Uchiyama; H Kato; A Taguchi
Journal:  Osteoporos Int       Date:  2016-09-20       Impact factor: 4.507
View more
  1 in total

1.  Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.

Authors:  D Miyaoka; Y Imanishi; M Ohara; N Hayashi; Y Nagata; S Yamada; K Mori; M Emoto; M Inaba
Journal:  Osteoporos Int       Date:  2018-09-05       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.